Skip to the page

Data / Form D filings / Veravas, Inc.

Veravas, Inc.: Form D filings

Veravas, Inc., a health care company in Austin, TX, filed 3 Form D notices with the SEC between 2019 and 2024. The latest, on April 1, 2024, reports $20.6 million sold of a $26.4 million offering to 138 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
111 Congress Avenue, Suite 500, Austin, TX, 78701
Phone
(512) 489-1731
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1789835

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 1, 2024New notice$26,379,251$20,579,251$5,800,000138Mar 15, 2024sec.gov
Mar 29, 2023New notice$50,000,000$775,000$49,225,00012Oct 11, 2022sec.gov
Oct 1, 2019New notice$2,000,000$375,000$1,625,0006Sep 16, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jeremy CooteDirector
James KyleDirector
John ForrestExecutive Officer, Director, Promoter
Luc VanhalExecutive Officer
Will KikerDirector

Other health care companies in Texas that filed recently

Every Form D from the week of Apr 1, 2024 · All recent filings in Texas · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Veravas, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.